👀 Ones to watch: Undervalued stocks to buy before they report Q3 earningsSee Undervalued Stocks

Nu Skin Soars on Higher Forecast, Triples Since March

Published 02/07/2020, 15:49
Updated 02/07/2020, 15:51
© Reuters.
NUS
-

By Christiana Sciaudone

Investing.com -- Nu Skin Enterprises Inc. soared 25% on Thursday after the company raised estimated revenue for the second quarter. Shares have almost tripled since March.

Sales should range between $603 million to $608 million, up from a previous forecast of $520 million to $550 million. Results will be reported on August 5. That’s still lower than the second quarter of 2019, when Nu Skin reported revenue of $625.3 million. Sales for the second quarter of 2018 were reported at $704.2 million.

The anti-aging supplement maker based in Utah cited strong customer growth in the Americas and Europe for the increase in revenue. 

In the past, Nu Skin has been accused by investors and Chinese regulators of running a pyramid scheme.

 

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.